Genipin Enhances the Therapeutic Effects of Oxaliplatin by Upregulating BIM in Colorectal Cancer

Molecular Cancer Therapeutics
Bo Ram KimSang Cheul Oh

Abstract

Despite an increase in the survival rate of patients with cancer owing to the use of current chemotherapeutic agents, adverse effects of cancer therapies remain a concern. Combination therapies have been developed to increase efficacy, reduce adverse effects, and overcome drug resistance. Genipin is a natural product derived from Gardenia jasminoides, which has been associated with anti-inflammatory, anti-angiogenic, and anti-proliferative effects; hypertension; and anti-ischemic brain injuries. However, the enhancement of oxaliplatin sensitivity by genipin remains unexplored. Our study showed that a combination of genipin and oxaliplatin exerts synergistic antitumor effects in vitro and in vivo in colorectal cancer cell lines through the reactive oxygen species (ROS)/endoplasmic reticulum (ER) stress/BIM pathway. Importantly, the combination did not affect normal colon cells. BIM knockdown markedly inhibited apoptosis induced by the combination. In addition, genipin induced ROS by inhibiting superoxide dismutase 3 activity. These findings suggest that genipin may be a novel agent for increasing the sensitivity of oxaliplatin against colorectal cancer. The combination of oxaliplatin and genipin hold significant therapeutic pote...Continue Reading

References

Feb 28, 1998·The EMBO Journal·L O'ConnorD C Huang
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·B L BennettD W Anderson
Jun 27, 2003·Biochemical Pharmacology·Sandrine FaivreJan M Woynarowski
Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Douglas HagrmanAbdul-Kader Souid
Mar 25, 2004·Nature Reviews. Immunology·J David Lambeth
Apr 7, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharlene GillRichard M Goldberg
Jun 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alvaro FigueredoLisa Zuraw
Oct 4, 2005·The Journal of Clinical Investigation·Chunyan XuJohn C Reed
Jul 13, 2007·Nature Reviews. Cancer·Lloyd Kelland
Oct 20, 2007·Clinical Colorectal Cancer·Isabel Moreno-SolórzanoBernat Gel-Moreno
Dec 13, 2007·Nature Reviews. Molecular Cell Biology·Rebecca C TaylorSeamus J Martin
Dec 14, 2007·Molecular Biology of the Cell·Samuel B Stephens, Christopher V Nicchitta
Apr 23, 2008·The Biochemical Journal·Nuria GarridoJosé Antonio Enríquez
Dec 2, 2008·Nature Reviews. Drug Discovery·Inki KimJohn C Reed
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thierry AndréAimery de Gramont
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
Jul 3, 2009·Biological & Pharmaceutical Bulletin·Masayuki TanakaKenzo Chiba
Jan 5, 2010·Free Radical Biology & Medicine·Magdalena L Circu, Tak Yee Aw
Jan 9, 2010·Circulation Research·Hui Cheng, Thomas Force
Feb 4, 2010·International Immunopharmacology·Kyong Nyon NamEunjoo H Lee
Mar 8, 2011·Microbial Biotechnology·Arnold L Demain, Preeti Vaishnav
May 14, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Uwe PelzerHelmut Oettle
Jul 5, 2011·Journal of Cellular and Molecular Medicine·Karen M DoyleAfshin Samali
Aug 31, 2011·Cold Spring Harbor Perspectives in Biology·Kazutaka Araki, Kazuhiro Nagata
May 26, 2012·Journal of the Royal Society, Interface·Marjorie S AusteroCaroline L Schauer
Jul 16, 2013·Biochimica Et Biophysica Acta·Renata Sano, John C Reed
Sep 21, 2013·Apoptosis : an International Journal on Programmed Cell Death·Ranjita DasChitra Mandal
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Feb 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maria Di BartolomeoEmilio Bajetta
Mar 8, 2016·International Journal of Molecular Sciences·Hafiz Maher Ali ZeeshanHan-Jung Chae
Apr 24, 2016·International Journal of Biological Macromolecules·Riccardo A A MuzzarelliAntonio Gigante
Jun 14, 2016·Oxidative Medicine and Cellular Longevity·Mikko O Laukkanen
Jul 2, 2016·Nature Reviews. Cancer·Gabriel Ichim, Stephen W G Tait

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.